Despite many conflicting reports about the prognostic significance of BRCA1 mutations in breast cancer patients (where patients with different mutations were usually combined in common groups) [18-20], the influence of individual BRCA1 mutations on the clinical outcomes of breast cancer patients has not been fully investigated. This evidence concerns the gene BRCA1 and breast carcinoma.